(NASDAQ: BNOX) Bionomics Limited's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.97%.
Bionomics Limited's earnings in 2024 is -$10,684,252.On average, 1 Wall Street analyst forecast BNOX's earnings for 2025 to be -$4,520,611,153, with the lowest BNOX earnings forecast at -$4,520,611,153, and the highest BNOX earnings forecast at -$4,520,611,153.
In 2026, BNOX is forecast to generate -$17,833,031,582 in earnings, with the lowest earnings forecast at -$17,833,031,582 and the highest earnings forecast at -$17,833,031,582.